Fidelity Disruptive Medicine ETF (NASDAQ:FMED) Shares Bought by Jane Street Group LLC

Jane Street Group LLC lifted its stake in shares of Fidelity Disruptive Medicine ETF (NASDAQ:FMED) by 200.4% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 61,342 shares of the company’s stock after purchasing an additional 40,924 shares during the quarter. Jane Street Group LLC owned about 2.92% of Fidelity Disruptive Medicine ETF worth $1,613,000 as of its most recent filing with the Securities and Exchange Commission.

Separately, Wealth Enhancement Advisory Services LLC increased its position in Fidelity Disruptive Medicine ETF by 3.7% in the third quarter. Wealth Enhancement Advisory Services LLC now owns 539,827 shares of the company’s stock worth $14,192,000 after buying an additional 19,240 shares during the period.

Fidelity Disruptive Medicine ETF Stock Performance

Shares of FMED opened at $25.23 on Friday. The firm has a fifty day moving average of $25.78 and a 200-day moving average of $25.34. The company has a market cap of $52.98 million, a price-to-earnings ratio of 35.73 and a beta of 0.94. Fidelity Disruptive Medicine ETF has a 1 year low of $23.32 and a 1 year high of $26.68.

Fidelity Disruptive Medicine ETF Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, December 24th. Shareholders of record on Friday, December 20th were paid a dividend of $0.112 per share. This represents a $0.45 dividend on an annualized basis and a yield of 1.78%. This is a positive change from Fidelity Disruptive Medicine ETF’s previous quarterly dividend of $0.00. The ex-dividend date was Friday, December 20th.

About Fidelity Disruptive Medicine ETF

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.